Streetbeat News

Stock Prices

IMCC

IM Cannabis Corp. (NASDAQ:IMCC) is undertaking a $1.6M non-brokered private placement offering to repay a loan. The offering includes shares and warrants, with a closing expected by Nov. 11, 2024. Recent strategic moves include a share consolidation and strong financial performance, particularly in Germany.

Portfolio Pulse from Jelena Martinovic

October 04, 2024 | 5:09 pm

AAL

DAL

JBLU

LTM

SAVE

UAL

Spirit Airlines is considering bankruptcy after a failed merger with JetBlue, which was blocked by U.S. antitrust regulators. The airline faces financial struggles due to engine issues and intense competition. The stock has dropped significantly, losing over 85% of its value in 2024.

Portfolio Pulse from Anthony Noto

October 04, 2024 | 5:09 pm

HPQ

TSLA

WBD

Tesla's CIO, Nagesh Saldi, has resigned ahead of a major Robotaxi event, continuing a trend of executive departures in 2024. Tesla's stock has been down due to demand weakness and competition, with analysts predicting a potential downside in 2025.

Portfolio Pulse from Anusuya Lahiri

October 04, 2024 | 5:07 pm

Analysts have mixed views on Zoom Video Communications (NASDAQ:ZM) with recent ratings showing a range from bullish to bearish. The average 12-month price target is $74.25, with a slight decrease in sentiment. Financial performance shows positive revenue growth and strong net margins, but challenges in ROE.

Portfolio Pulse from Benzinga Insights

October 04, 2024 | 5:04 pm

ITCI

Intra-Cellular Therapies (NASDAQ:ITCI) has received mixed analyst ratings over the past three months, with a majority being somewhat bullish. The average 12-month price target has increased to $102.5. The company shows strong revenue growth but faces challenges in profitability and returns.

Portfolio Pulse from Benzinga Insights

October 04, 2024 | 5:04 pm

LPLA

Analysts have provided mixed evaluations for LPL Financial Holdings (NASDAQ:LPLA) over the past three months, with a range of ratings from bullish to indifferent. The average 12-month price target has decreased by 5.81% to $279.53. Despite strong revenue growth and financial performance, LPL's market capitalization and net margin are below industry averages.

Portfolio Pulse from Benzinga Insights

October 04, 2024 | 5:03 pm

UNG

USO

The latest Baker Hughes report shows a decrease in the U.S. oil rig count by 5 to 479, while the natural gas rig count increased by 3 to 102. The total rig count is now 585, down from 587 previously.

Portfolio Pulse from Benzinga Newsdesk

October 04, 2024 | 5:02 pm

FANG

Diamondback Energy's stock is trading higher following an upgrade by BMO Capital from Market Perform to Outperform, with a price target increase from $205 to $215.

Portfolio Pulse from Benzinga Newsdesk

October 04, 2024 | 5:01 pm

JAZZ

Jazz Pharmaceuticals (NASDAQ:JAZZ) has been analyzed by 12 financial analysts, showing a range of opinions from bullish to bearish. The average 12-month price target is $169.25, a decrease from the previous $173.33. Analysts have adjusted their ratings and price targets, reflecting their views on the company's performance. Jazz Pharmaceuticals has shown a positive revenue trend with a 6.95% growth rate, strong net margin, and effective asset utilization, but faces challenges with below-average ROE.

Portfolio Pulse from Benzinga Insights

October 04, 2024 | 5:01 pm

ARES

CRWD

DECK

The CNBC Halftime Report highlighted final trades including Deckers Outdoor, Citigroup, Ares Management Corp, and CrowdStrike. These companies were discussed as potential investment opportunities.

Portfolio Pulse from Benzinga Newsdesk

October 04, 2024 | 5:01 pm